4-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYLTRIAZOL-4-YL]-N-METHYL-N-PROPAN-2-YL-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXAMIDE
概述 用途与合成方法 MSDS 4-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYLTRIAZOL-4-YL]-N-METHYL-N-PROPAN-2-YL-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXAMIDE价格(试剂级) 上下游产品信息
| 中文名称 | 4-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYLTRIAZOL-4-YL]-N-METHYL-N-PROPAN-2-YL-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXAMIDE |
|---|---|
| 中文同义词 | 化合物FTIDC;FTIDC,MGLU1受体的负变构调节剂;化合物FTIDC,10 MM DMSO 溶液 |
| 英文名称 | FTIDC |
| 英文同义词 | FTIDC;4-[1-(2-fluoropyridin-3-yl)-5-methyltriazol-4-yl]-N-methyl-N-propan-2-yl-3,6-dihydro-2H-pyridine-1-carboxamide;4-[1-(2-Fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-3,6-dihydro-N-methyl-N-(1-methylethyl)-1(2H)-pyridinecarboxamide;1(2H)-Pyridinecarboxamide, 4-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-3,6-dihydro-N-methyl-N-(1-methylethyl)-;mGluR,Metabotropic glutamate receptors,inhibit,Inhibitor,FTIDC;FTIDC, 10 mM in DMSO |
| CAS号 | 873551-53-2 |
| 分子式 | C18H23FN6O |
| 分子量 | 358.41 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 873551-53-2.mol |
| 结构式 | ![4-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYLTRIAZOL-4-YL]-N-METHYL-N-PROPAN-2-YL-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXAMIDE 结构式](CAS/20200515/GIF/873551-53-2.gif) |
4-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYLTRIAZOL-4-YL]-N-METHYL-N-PROPAN-2-YL-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXAMIDE 性质
| 储存条件 | Store at -20°C |
|---|---|
| 溶解度 | 溶于二甲基亚砜 |
| 形态 | 固体 |
4-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYLTRIAZOL-4-YL]-N-METHYL-N-PROPAN-2-YL-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXAMIDE 用途与合成方法
FTIDC 是一种口服，非竞争性，选择性的变构代谢型谷氨酸受体 1 (mGluR 1) 拮抗剂，对人 mGluR1a 的 IC50 为 5.8 nM。FTIDC 对人，小鼠和大鼠的重组 mGluR1 的拮抗活性没有物种差异。
安全信息
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2025/12/22 | HY-100405 | FTIDC | 873551-53-2 | 1 mg | 1104元 |
| 2025/12/22 | HY-100405 | 4-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYLTRIAZOL-4-YL]-N-METHYL-N-PROPAN-2-YL-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXAMIDE FTIDC | 873551-53-2 | 5 mg | 2900元 |